EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.14.55 | etoposide + NADPH + O2 |
- |
Homo sapiens |
3'-demethyletoposide + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + NADPH + O2 |
- |
Mus musculus |
3-hydroxyquinine + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + NADPH + O2 |
- |
Homo sapiens |
3-hydroxyquinine + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + NADPH + O2 |
- |
Rattus norvegicus |
3-hydroxyquinine + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + NADPH + O2 |
- |
Canis lupus familiaris |
3-hydroxyquinine + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + NADPH + O2 |
quinine is used for treatment of severe forms of Plasmodium falciparum malaria, phenotyping of two different populations, overview |
Homo sapiens |
3-hydroxyquinine + NADP+ + H2O |
- |
? |
1.14.14.55 | quinine + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
3-hydroxyquinine + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.55 | quinine + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Pygoscelis adeliae |
3-hydroxyquinine + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.55 | tacrolimus + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
? |
- |
? |
1.14.14.55 | teniposide + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
teniposide catechol + [oxidized NADPH-hemoprotein reductase] + ? |
- |
? |